Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Gains from Sales and Divestitures (2014 - 2023)

Updated

Ligand Pharmaceuticals' Gains from Sales and Divestitures was $53.07 million in FY2025.

Analysis

Ligand Pharmaceuticals (LGND) Gains from Sales and Divestitures (2014 - 2023) Analysis & Trends

From FY2016 onward, Ligand Pharmaceuticals has reported Gains from Sales and Divestitures for 5 years.

  • Gains from Sales and Divestitures shows a five-year compound annual growth rate of 25.4% (FY2020 to FY2025).
  • The FY2025 figure marks the highest annual Gains from Sales and Divestitures since FY2019.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was $2.12 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 2.12 Mn
Dec 31, 2020 17.11 Mn
Mar 31, 2019 812.80 Mn
Sep 30, 2016 -50,000.00
Dec 31, 2014 -16,000.00
API Access

Ligand Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LGND&period=max&api_key=YOUR_API_KEY